Last reviewed · How we verify

NCT05732090

Effect of Diaphragmatic Myofascial Release on Thoracic Angle and Pulmonary Functions in Hyperkyphotic Adolescents

Completed NA Last updated 22 May 2024
What this trial tests

NA trial testing therapeutic exercise program in Adolescent Kyphosis in 102 participants. Completed in 30 May 2023.

Timeline
25 February 2022
Primary endpoint
30 May 2023
30 May 2023

Quick facts

Lead sponsorDelta University for Science and Technology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment102
Start date25 February 2022
Primary completion30 May 2023
Estimated completion30 May 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Delta University for Science and Technology

Who can join

Adults 12 to 15, female only, with Adolescent Kyphosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adolescent kyphotic girls will participate in this study. They will be divided into two groups. Group A: The control group will receive a therapeutic exercise program. Group B: The study group will receive the same intervention as Group A in addition to diaphragmatic myofascial release. They will be assessed at baseline and after three successive months of interventions for the following outcomes: Cobb angle by x-ray and pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) by computerized spirometer

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of therapeutic exercise program

Trials testing the same drug.

Other Delta University for Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05732090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing